These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8931614)

  • 21. Why do African-American men suffer more prostate cancer?
    McIntosh H
    J Natl Cancer Inst; 1997 Feb; 89(3):188-9. PubMed ID: 9016996
    [No Abstract]   [Full Text] [Related]  

  • 22. Asymptomatic incidence and duration of prostate cancer.
    Etzioni R; Cha R; Feuer EJ; Davidov O
    Am J Epidemiol; 1998 Oct; 148(8):775-85. PubMed ID: 9786232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer statistics, 2015: Convergence of incidence rates between black and white women.
    DeSantis CE; Fedewa SA; Goding Sauer A; Kramer JL; Smith RA; Jemal A
    CA Cancer J Clin; 2016; 66(1):31-42. PubMed ID: 26513636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contrasting trends of prostate cancer incidence and mortality in New Mexico's Hispanics, non-Hispanic whites, American Indians, and blacks.
    Gilliland FD; Becker TM; Key CR; Samet JM
    Cancer; 1994 Apr; 73(8):2192-9. PubMed ID: 8156525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do African American men have lower survival from prostate cancer compared with White men? A meta-analysis.
    Sridhar G; Masho SW; Adera T; Ramakrishnan V; Roberts JD
    Am J Mens Health; 2010 Sep; 4(3):189-206. PubMed ID: 20483872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Association of African-American ethnic background with survival in men with metastatic prostate cancer.
    Polednak AP
    J Natl Cancer Inst; 2001 Aug; 93(15):1174-5. PubMed ID: 11481391
    [No Abstract]   [Full Text] [Related]  

  • 27. African-Americans and prostate cancer: why the discrepancies?
    Jones J
    J Natl Cancer Inst; 2001 Mar; 93(5):342-4. PubMed ID: 11238694
    [No Abstract]   [Full Text] [Related]  

  • 28. Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates.
    Merrill RM; Weed DL
    Ann Epidemiol; 2001 Nov; 11(8):547-53. PubMed ID: 11709274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contemporary risk profile of prostate cancer in the United States.
    Shao YH; Demissie K; Shih W; Mehta AR; Stein MN; Roberts CB; Dipaola RS; Lu-Yao GL
    J Natl Cancer Inst; 2009 Sep; 101(18):1280-3. PubMed ID: 19713548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in the prevalence of modifiable risk and protective factors for prostate cancer by race and ethnicity in the National Health and Nutrition Examination Survey.
    Defever K; Platz EA; Lopez DS; Mondul AM
    Cancer Causes Control; 2020 Sep; 31(9):851-860. PubMed ID: 32666408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer in black and white Americans.
    Reddy S; Shapiro M; Morton R; Brawley OW
    Cancer Metastasis Rev; 2003 Mar; 22(1):83-6. PubMed ID: 12716039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Steele CB; Li J; Huang B; Weir HK
    Cancer; 2017 Dec; 123 Suppl 24(Suppl 24):5160-5177. PubMed ID: 29205313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testicular cancer incidence trends in the USA (1975-2004): plateau or shifting racial paradigm?
    Holmes L; Escalante C; Garrison O; Foldi BX; Ogungbade GO; Essien EJ; Ward D
    Public Health; 2008 Sep; 122(9):862-72. PubMed ID: 18555499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Income inequality and treatment of African American men with high-risk prostate cancer.
    Ziehr DR; Mahal BA; Aizer AA; Hyatt AS; Beard CJ; D Amico AV; Choueiri TK; Elfiky A; Lathan CS; Martin NE; Sweeney CJ; Trinh QD; Nguyen PL
    Urol Oncol; 2015 Jan; 33(1):18.e7-18.e13. PubMed ID: 25306287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.
    Mahal BA; Ziehr DR; Aizer AA; Hyatt AS; Sammon JD; Schmid M; Choueiri TK; Hu JC; Sweeney CJ; Beard CJ; D'Amico AV; Martin NE; Lathan C; Kim SP; Trinh QD; Nguyen PL
    Urol Oncol; 2014 Nov; 32(8):1285-91. PubMed ID: 24846344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in prostate cancer: United States, 1980 to 1988.
    Oncology (Williston Park); 1993 Apr; 7(4):18-20, 23. PubMed ID: 8485032
    [No Abstract]   [Full Text] [Related]  

  • 38. Patterns in cancer incidence among American Indians/Alaska Natives, United States, 1992-1999.
    Paltoo DN; Chu KC
    Public Health Rep; 2004; 119(4):443-51. PubMed ID: 15219802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
    Dall'Era MA; deVere-White R; Rodriguez D; Cress R
    Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial differences in clinical progression among Medicare recipients after treatment for localized prostate cancer (United States).
    Cohen JH; Schoenbach VJ; Kaufman JS; Talcott JA; Schenck AP; Peacock S; Symons M; Amamoo MA; Carpenter WR; Godley PA
    Cancer Causes Control; 2006 Aug; 17(6):803-11. PubMed ID: 16783608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.